Disease modifying efficacy of memantine in Alzheimer’s disease; a pooled analysis of 13 randomized controlled trials
0
Authors
D. Emadeldin
D. Emadeldin•Ali Ramadan•Ahmed Negida
Published
October 1, 2017
Abstract
Background: Memantine is an FDA approved symptomatic treatment for Alzheimer’s disease (AD). However, its disease modifying efficacy remains controversial.
